Martin Wasserbauer

Statistics

Publications

Citations

155

H-Index

Active since

2016

Affiliations

Charles University(Current)

Krajská nemocnice T. Bati

University Hospital Plzen

Martin Wasserbauer is an author at Charles University specializing in pharmacotherapy, ulcerative colitis pharmacotherapy, and inflammatory bowel disease.

ORCID

Publications per year

2016–2022

Publications

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis

Radan Keil, Martin Wasserbauer, Zdena Zádorová et al. · Scandinavian Journal of Gastroenterology · 2016 · 63 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +16

ERCP in infants, children, and adolescents—Different roles of the methods in different age groups

Radan Keil, Jindra Lochmannová, Jan Šťovíček et al. · PLoS ONE · 2019 · 54 citations · Full text

Medicine, Child Health, Pediatrics +15

Adherence, risk factors of non-adherence and patient’s preferred treatment strategy of mesalazine in ulcerative colitis: multicentric observational study

Radan Keil, Martin Wasserbauer, Zdena Zádorová et al. · Scandinavian Journal of Gastroenterology · 2018 · 28 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring

Martin Wasserbauer, Štěpán Hlava, Jan Šťovíček et al. · PLoS ONE · 2022 · 10 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

1–4 of 4